244101-03-9

L-826266 is a EP(1) receptor antagonist.

L-826266 is a selective and competitive EP3 receptor antagonist. L-826266 can be used for convulsive disorders research[1].

EP3

[1] M S Oliveira, et al. Modulation of pentylenetetrazol-induced seizures by prostaglandin E2 receptors. Neuroscience. 2008 Apr 9;152(4):1110-8. DOI:10.1016/j.neuroscience.2008.01.005
[2] Mauro Schneider Oliveira, et al. Prostaglandin E2 modulates Na+,K+-ATPase activity in rat hippocampus: implications for neurological diseases. J Neurochem. 2009 Apr;109(2):416-26. DOI:10.1111/j.1471-4159.2009.05961.x